Kevin Chih-Yuan Ho

Director of Business and Clinical Development at Steminent Biotherapeutics
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Taiwan, TW
Languages
  • English -
  • Chinese (Traditional) -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Taiwan
    • Biotechnology Research
    • 1 - 100 Employee
    • Director of Business and Clinical Development
      • Mar 2020 - Present

      Steminent Biotherapeutics Inc. is a global clinical-stage biopharmaceutical company devotes to stem cell therapies for unmet medical needs at its phase II stage. With the established proprietary technology platform and manufacturing capacity, Steminent is conducting two phase II clinical trials in USA and Taiwan and, with its partner, conducting one phase II clinical trial in Japan.

    • Manager of Business Development / Special Assistant to CEO
      • Mar 2014 - Mar 2020

    • Manager of Business Development / Special Assistant to President
      • Dec 2012 - Mar 2014

    • Manager of Medical Department
      • Apr 2012 - Dec 2012

    • President
      • Dec 2011 - Apr 2012

      The association works closely with the Taipei Representative Office in the UK to provide essential help and information to the alumni in the UK. The association works closely with the Taipei Representative Office in the UK to provide essential help and information to the alumni in the UK.

    • United Kingdom
    • Financial Services
    • 1 - 100 Employee
    • Internship Trainee
      • Nov 2011 - Apr 2012

      SinoPac Securities is one of the leading securities firms in Taiwan which was ranked as “Best Underwriter” in 2004 and 2005 and as No.2 in Brokerage in Taiwan. SinoPac London office provides investment strategies and company research reports of Taiwan and Asia stock market to its Foreign Institutional Investors (FINIs). SinoPac Securities is one of the leading securities firms in Taiwan which was ranked as “Best Underwriter” in 2004 and 2005 and as No.2 in Brokerage in Taiwan. SinoPac London office provides investment strategies and company research reports of Taiwan and Asia stock market to its Foreign Institutional Investors (FINIs).

  • SHEN JIN Engineering CO., LTD
    • London, United Kingdom
    • Project Consultant
      • May 2011 - Apr 2012

      The company devotes in construction industry and international trading of used cranes between Europe and Taiwan. The company devotes in construction industry and international trading of used cranes between Europe and Taiwan.

    • United Kingdom
    • Research Services
    • 700 & Above Employee
    • Lead Technician
      • Apr 2009 - Feb 2011

    • Taiwan
    • Hospitals and Health Care
    • 700 & Above Employee
    • Research Assistant
      • Feb 2004 - Nov 2005

Education

  • University College London, U. of London
    PhD, Biomedical Engineering
    2006 - 2011
  • National Taiwan University
    Bsc, Agricultural Chemistry
    1998 - 2002

Community

You need to have a working account to view this content. Click here to join now